Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period
- PMID: 19365121
- PMCID: PMC2814021
- DOI: 10.1159/000211803
Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period
Abstract
Background/aims: To investigate the longitudinal stability and progression of different subtypes of mild cognitive impairment (MCI) in older adults.
Methods: We classified 217 individuals with no cognitive impairment (NCI), amnestic MCI (aMCI) based on a single test (aMCI-1) or multiple tests (aMCI-2+), nonamnestic MCI (naMCI) based on a single test (naMCI-1) or multiple tests (naMCI-2+), or amnestic + nonamnestic MCI (a+naMCI), using their baseline neuropsychological test scores, and performed annual follow-up evaluations for up to 3 years.
Results: None of the subjects with aMCI-2+ reverted to normal during follow-up, with 50% of these subjects remaining stable and 50% worsening over time. Similarly, less than 20% of subjects with aMCI-2+ and a+naMCI reverted to NCI during the follow-up period, whereas 50% of aMCI-1 and 37% with naMCI-1 reverted to NCI during this same period.
Conclusion: Reversion to NCI occurs much more frequently when the diagnosis of MCI is based on the results of a single neuropsychological test than when it is based on the results of more memory tests. In epidemiological studies and clinical trials the diagnosis of MCI will likely be more stable if impairment on more than one test is required for amnestic and/or nonamnestic domains.
References
-
- Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R. Mild cognitive impairment: directions for future research. Neurology. 2003;61:438–444. - PubMed
-
- Albert M, Blacker D, Moss MB, Tanzi R, McArdle JJ. Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology. 2007;21:158–169. - PubMed
-
- Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev. 2000;24:365–374. - PubMed
-
- Testa JA, Ivnik RJ, Boeve B, Petersen RC, Pankratz VS, Knopman D, Tangalos E, Smith GE. Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease. J Int Neuropsychol Soc. 2004;10:504–512. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
